BML Capital Management, LLC - ARCA BIOPHARMA INC ownership

ARCA BIOPHARMA INC's ticker is ABIO and the CUSIP is 00211Y506. A total of 25 filers reported holding ARCA BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BML Capital Management, LLC ownership history of ARCA BIOPHARMA INC
ValueSharesWeighting
Q1 2024$1,244,197
+3.5%
706,9300.0%0.82%
-9.9%
Q4 2023$1,201,781
-15.4%
706,9300.0%0.91%
-30.3%
Q3 2023$1,420,929
-1.0%
706,9300.0%1.30%
+1.1%
Q2 2023$1,435,068
+2.0%
706,9300.0%1.29%
+6.2%
Q1 2023$1,406,791
-30.8%
706,930
-17.6%
1.22%
-37.4%
Q4 2022$2,034,067858,2561.94%
Other shareholders
ARCA BIOPHARMA INC shareholders Q2 2023
NameSharesValueWeighting ↓
Newtyn Management, LLC 500,000$1,030,0000.23%
SG3 Management, LLC 200,000$412,0000.03%
Marquette Asset Management, LLC 17,318$36,0000.01%
SG3 Management, LLC 75,412$155,6740.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 46,948$97,0000.00%
Tekla Capital Management LLC 32,461$67,0000.00%
Virtu Financial LLC 14,221$29,0000.00%
GROUP ONE TRADING, L.P. 144,284$297,0000.00%
WELLS FARGO & COMPANY/MN 96$00.00%
NORTHERN TRUST CORP 17,517$36,0000.00%
View complete list of ARCA BIOPHARMA INC shareholders